MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
Prepared Foods
October 2007
Mark Hostetler
Article: Regulations: Scientific Health Claims Review FDA's draft guidance on evidence-based health claims is aimed to help producers evaluate and understand the strength of evidence in supporting health claims. mark for My Articles similar articles
Food Processing
February 2008
David Joy
Some health claims in jeopardy FDA is re-evaluating health claims for soy, antioxidant vitamins and fat-cancer. mark for My Articles similar articles
Food Processing
April 2005
David Joy
Regulatory Issues: Serving up whole grains With consumers increasingly aware of the benefits of whole grains, a simple, factual label statement about their presence may suffice. But many food manufacturers want to make label claims, so the the question is: What exactly can be said about whole grains on a food label? mark for My Articles similar articles
Food Processing
February 2005
David Joy
Regulatory Issues: Generally recognized meaning of GRAS The GRAS exception exists so the FDA does not spend valuable resources reviewing things that clearly are safe. mark for My Articles similar articles
Prepared Foods
August 11, 2006
Enrichment and Health Claims This article highlights several threshold legal principles that govern what nutrients may be added to which foods and at what levels. mark for My Articles similar articles
Entrepreneur
March 2005
Stephen Barlas
Just the facts The FDA doesn't want any more lies on dietary supplement labels... Is Sarbanes-Oxley a Class Act?... etc. mark for My Articles similar articles
Prepared Foods
January 1, 2006
FDA and Tomato Benefit Claims Federal regulators have cleared the way for food companies to cite certain cancer benefits by tomatoes in ads and on food labels, but excluded tomato-based dietary supplements. mark for My Articles similar articles
Prepared Foods
September 1, 2006
William A. Roberts, Jr.
Claiming a Function Functional foods can claim preventative health benefits, but be careful to not infer a cure-all food. mark for My Articles similar articles
Food Processing
August 2006
David Joy
Regulatory Issues: Opportunities and challenges of functional ingredients There is more than one way to conclude whether a functional ingredient intended for addition to food is legal. mark for My Articles similar articles
Food Processing
January 2005
David Joy
Regulatory Issues: The FDA agenda for 2005 As in the past, the FDA has a full agenda of food regulatory matters in 2005. So it's not good that the FDA's scientists are demoralized and the agency stands accused of being too friendly with a regulated industry. mark for My Articles similar articles
Prepared Foods
October 1, 2006
Steven B. Steinborn
An Apple a Day...but How Big an Apple? When deciding how much of an ingredient or nutrient must be added to a product to justify its advertising claim, certain regulatory guideposts should be followed. mark for My Articles similar articles
Prepared Foods
May 4, 2007
Mark Hostetler
Claims Substantiation for Weight Management Products There is regulatory guidance available to help answer the question of how much and what kind of claims support is required. mark for My Articles similar articles
Pharmaceutical Executive
July 1, 2011
Jill Wechsler
Battles over Biosimilars Sponsors must handle interchangeability, exclusivity, cost and coverage hurdles to win biosimilars game. mark for My Articles similar articles
Food Processing
January 2007
David Joy
FDA considers functional foods There is no formal regulatory definition associated with the term "functional foods," but the FDA is soliciting information and comments on whether or not these foods should be regulated more strictly. mark for My Articles similar articles
Food Processing
March 2005
David Joy
Regulatory Issues: Regulatory impact of the new guidelines The federal government's recently issued 2005 Dietary Guidelines for Americans are primarily aimed at influencing the way Americans eat and exercise. But will the new recommendations also affect FDA's food labeling regulations? mark for My Articles similar articles
Pharmaceutical Executive
February 1, 2012
Jennifer Ringler
Industry Trees are Falling, But is FDA Around to Hear? Experts weigh in on FDA's long-awaited social media guidelines. mark for My Articles similar articles
Science News
September 25, 2004
Janet Raloff
Omega-3's May Hit Food Labels The FDA will allow food manufacturers to make health claims for two omega-3 fatty acids, oils typically found in coldwater fish. Food labels can now note that products containing these oils might provide some protection from heart disease. mark for My Articles similar articles
Pharmaceutical Executive
March 1, 2006
Jill Wechsler
Washington Report: Labels and Liability New FDA guidance aims at better communication of risks. But it creates some, too. mark for My Articles similar articles
Nutra Solutions
January 9, 2008
Ginny Bank
Conquering Cardiovascular Disease Beneficial heart-healthy ingredients include dietary fiber, omega-3s and certain oils, phytosterols and soy protein. mark for My Articles similar articles
Food Processing
March 2006
Dave Fusaro
One more step needed on grains The FDA has left it up to food marketers to decide if its guidance on whole-grain content is appropriate. And they have until April 17th to do so. mark for My Articles similar articles
Pharmaceutical Executive
August 1, 2012
Jill Wechsler
Fleshing Out FDASIA Medical apps, e-submissions, counterfeit drugs, and imports tucked into fairly "clean" user-fee renewal legislation. In late June leading legislators reached across party lines to quickly approve the Food and Drug Administration Safety and Innovation Act. mark for My Articles similar articles
Pharmaceutical Executive
January 1, 2006
Clinton & Wechsler
What Ever Happened to Critical Path FDA's ambitious program to improve drug development disappeared from view almost as soon as it was announced. Suddenly, it's back, but is it here to stay? mark for My Articles similar articles
Food Engineering
February 1, 2007
Regulatory Watch FDA finds meat and milk from animal clones is as safe to eat as from conventionally bred animals. mark for My Articles similar articles
Prepared Foods
June 5, 2007
Mark Hostetler
Regulations: Corn Oil Claims The FDA approves a health claim relating to corn oil and reduced risk of heart disease and changes to irradiation regulations. mark for My Articles similar articles
Pharmaceutical Executive
December 1, 2005
Jill Wechsler
Washington Report: Big Production Drug manufacturing costs too much and is cumbersome to regulate. FDA's answer: Quality by design, which shifts the emphasis from testing the final product to building quality into the manufacturing process from the beginning. mark for My Articles similar articles
Food Engineering
June 2, 2009
FDA Should Take Over Produce Safety Standards FDA leadership may be needed to determine sound science and make certain there is a level playing field in the industry. mark for My Articles similar articles
Food Processing
July 2013
Dunkiel & Boucher
Be Careful in Making Product Claims Marketing claims, especially regarding 'natural,' raise your legal risks. mark for My Articles similar articles
Pharmaceutical Executive
March 1, 2012
Jill Wechsler
When Talk is Not So Cheap FDA and industry are pushing user fees, while they struggle with curbs on communications. mark for My Articles similar articles
Food Processing
November 2007
David Joy
Regulatory Issues: New rules on reporting contamination Manufacturers will not have the option of handing recalls quietly. Information may even appear on FDA's web site. mark for My Articles similar articles
Chemistry World
January 21, 2010
Rebecca Renner
FDA shifts on BPA safety The US Food and Drug Administration has revised its position on the possible developmental health risks from bisphenol A, the controversial and widely used ingredient in hard plastic bottles and food packaging that it declared safe in 2008. mark for My Articles similar articles
IndustryWeek
October 19, 2011
FDA: A Future Innovation Partner? Could the Food and Drug Administration reform itself to help manufacturers create new medical technologies? mark for My Articles similar articles
The Motley Fool
August 18, 2011
Brian Orelli
Running the Correct Trial Isn't Enough MELA Sciences' stock is up on claim that their trial meets FDA guidance, but they still need to prove that the device actually works. mark for My Articles similar articles
The Motley Fool
February 7, 2006
Stephen D. Simpson
Boston Scientific's Big Task The company won the battle for Guidant, but the hard work hasn't even begun. Value is value, and if Boston Scientific proves it can handle the considerable challenges ahead, this could ultimately be a very interesting stock again. mark for My Articles similar articles
The Motley Fool
March 27, 2008
Brian Orelli
Tougher Rules Could Help Stent Makers The FDA has finally issued draft guidance on the minimum requirements that it thinks companies need to fulfill to get drug-eluting stents approved. mark for My Articles similar articles
Food Engineering
April 3, 2009
FDA offers new salmonella guidance FDA has released a guidance entitled, Measures to Address the Risk for Contamination by Salmonella Species in Food Containing a Peanut-Derived Product as an Ingredient. mark for My Articles similar articles
Prepared Foods
January 1, 2006
William A. Roberts, Jr.
Dressing Down Now that low-carb introductions are on the downswing, manufacturers of dressings, marinades and sauces are finding new ways to attract interest. mark for My Articles similar articles
The Motley Fool
February 28, 2008
Brian Lawler
FDA's Mixed Signals for Theravance The FDA gives Theravance frustrating double messages about a lead drug. mark for My Articles similar articles
Food Processing
July 2005
David Joy
Regulatory Issues: What's in a name? The Food and Drug Administration and the U.S. Dept. of Agriculture recently published a joint proposal to amend their regulations dealing with food "standards of identity." mark for My Articles similar articles
Pharmaceutical Executive
June 1, 2012
Jill Wechsler
Innovation and Collaboration A rash of "pro-innovative" approaches for testing and regulating medical products offer ways to speed more new products to market. mark for My Articles similar articles
Bio-IT World
April 15, 2003
Janet Woodcock
FDA Director Explains the Changes The head of the Center for Drug Evaluation and Research discusses why the FDA is now kinder and gentler about Part 11 compliance. mark for My Articles similar articles
Pharmaceutical Executive
August 1, 2014
Jill Wechsler
Social Media Struggles Continue Tweeting limited, corrections okay, says FDA, as industry, regulators wrestle with the digital world. mark for My Articles similar articles
Food Processing
March 2013
Biderman & Young
How Food and Beverage Manufacturers Can Avoid Class Action Litigation The recent suits against energy drink makers are lessons for all food and beverage processors. mark for My Articles similar articles
Pharmaceutical Executive
October 1, 2006
George Koroneos
Pharm Exec Q&A: Inside View The Union of Concerned Scientists made revelations about the FDA's own scientific culture. Here, Francesca Grifo, director of scientific integrity program at UCS, talks about the findings. mark for My Articles similar articles
Food Processing
December 2010
Diane Toops
Wellness Food Trends: Healthier Foods for the Heart Foods can be a solution (though carefully worded) for the leading cause of death. mark for My Articles similar articles
Food Processing
August 2013
Eric Lindstrom
FDA Paints Itself Into a Corner with FSMA A federal judge orders the agency to issue overdue food safety rules by November ... which looks unrealistic. mark for My Articles similar articles
The Motley Fool
August 12, 2010
Brian Orelli
Turnaround Signal, or Just Noise on the Decline? Boston Scientific clears up an FDA warning letter -- four years later. mark for My Articles similar articles
Food Processing
June 2013
Bert Slonim
Caffeine Under Siege by the FDA FDA investigation could be just the beginning of regulatory and litigation battles. mark for My Articles similar articles
Bio-IT World
April 2007
John Russell
Whatever Happened to the Critical Path? Science progresses at its own rate and medical science is necessarily more cautious than other branches. But it feels like the lack of money and mindshare are turning the FDA's Critical Path Initiative into just another umbrella project. mark for My Articles similar articles
Pharmaceutical Executive
June 1, 2014
dos Santos & Leskin
Social Media and the In-House Counsel Social media poses a regulatory and litigation maze that must be carefully navigated by pharmaceutical companies. mark for My Articles similar articles
Food Processing
May 2006
David Joy
Regulatory Issues: FDA may cut food-contact program The agency's proposed budget may mean an end to the efficient and speedy Food Contact Notification Program -- and two- to five-year waits for reviews. mark for My Articles similar articles